Joëlle Roche

4.2k total citations
59 papers, 3.1k citations indexed

About

Joëlle Roche is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Joëlle Roche has authored 59 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 15 papers in Oncology. Recurrent topics in Joëlle Roche's work include Axon Guidance and Neuronal Signaling (21 papers), Angiogenesis and VEGF in Cancer (18 papers) and Epigenetics and DNA Methylation (11 papers). Joëlle Roche is often cited by papers focused on Axon Guidance and Neuronal Signaling (21 papers), Angiogenesis and VEGF in Cancer (18 papers) and Epigenetics and DNA Methylation (11 papers). Joëlle Roche collaborates with scholars based in France, United States and Japan. Joëlle Roche's co-authors include Harry A. Drabkin, Philìppe Bertrand, Robert M. Gemmill, Vincent Potiron, Patrick Nasarre, Bruno Constantin, Élisabeth Brambilla, Jonathan Clarhaut, Wilbur A. Franklin and Sophie Kusy and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Joëlle Roche

59 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joëlle Roche France 32 2.5k 887 752 394 291 59 3.1k
Esther Zwick Germany 11 2.3k 0.9× 415 0.5× 1.2k 1.6× 388 1.0× 297 1.0× 12 3.7k
Gretchen Bain United States 28 2.2k 0.9× 269 0.3× 534 0.7× 283 0.7× 254 0.9× 55 3.9k
Peter Ordentlich United States 29 2.9k 1.2× 500 0.6× 1.2k 1.6× 338 0.9× 132 0.5× 67 4.2k
Andreas Gschwind Germany 9 1.6k 0.7× 220 0.2× 1.1k 1.5× 311 0.8× 202 0.7× 10 2.7k
John P. O’Bryan United States 35 2.3k 0.9× 372 0.4× 708 0.9× 199 0.5× 968 3.3× 77 3.9k
Hua Miao United States 9 2.0k 0.8× 869 1.0× 684 0.9× 492 1.2× 393 1.4× 11 2.6k
Tse‐Ming Hong Taiwan 33 2.2k 0.9× 281 0.3× 993 1.3× 889 2.3× 312 1.1× 65 3.3k
Matthew I. Wahl United States 29 3.3k 1.3× 237 0.3× 845 1.1× 364 0.9× 683 2.3× 32 5.3k
Mireia Duñach Spain 30 2.5k 1.0× 572 0.6× 404 0.5× 223 0.6× 603 2.1× 54 3.2k
Jonathan A. Pachter United States 32 2.4k 1.0× 184 0.2× 1.7k 2.3× 664 1.7× 612 2.1× 137 4.4k

Countries citing papers authored by Joëlle Roche

Since Specialization
Citations

This map shows the geographic impact of Joëlle Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joëlle Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joëlle Roche more than expected).

Fields of papers citing papers by Joëlle Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joëlle Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joëlle Roche. The network helps show where Joëlle Roche may publish in the future.

Co-authorship network of co-authors of Joëlle Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Joëlle Roche. A scholar is included among the top collaborators of Joëlle Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joëlle Roche. Joëlle Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evanno, Emilie, et al.. (2017). Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer. Clinical Epigenetics. 9(1). 80–80. 43 indexed citations
2.
Nasarre, Patrick, Robert M. Gemmill, Vincent Potiron, et al.. (2013). Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-β1–Induced Epithelial–Mesenchymal Transition. Cancer Research. 73(23). 7111–7121. 55 indexed citations
3.
Thomas, Mickaël, Jonathan Clarhaut, Pierre‐Olivier Strale, et al.. (2011). A Galactosidase‐Responsive “Trojan Horse” for the Selective Targeting of Folate Receptor‐Positive Tumor Cells. ChemMedChem. 6(6). 1006–1010. 26 indexed citations
4.
Karayan‐Tapon, Lucie, Michel Wager, Joëlle Guilhot, et al.. (2008). Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?. British Journal of Cancer. 99(7). 1153–1160. 49 indexed citations
5.
Thomas, Mickaël, Jonathan Clarhaut, Isabelle Tranoy‐Opalinski, et al.. (2008). Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy. Bioorganic & Medicinal Chemistry. 16(17). 8109–8116. 35 indexed citations
6.
Potiron, Vincent, Joëlle Roche, & Harry A. Drabkin. (2008). Semaphorins and their receptors in lung cancer. Cancer Letters. 273(1). 1–14. 52 indexed citations
7.
Potiron, Vincent, Girish Sharma, Patrick Nasarre, et al.. (2007). Semaphorin SEMA3F Affects Multiple Signaling Pathways in Lung Cancer Cells. Cancer Research. 67(18). 8708–8715. 67 indexed citations
8.
Charrier, Cédric, Philìppe Bertrand, Jean‐Pierre Gesson, & Joëlle Roche. (2006). Synthesis of rigid trichostatin A analogs as HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5339–5344. 16 indexed citations
9.
Nasarre, Patrick, Bruno Constantin, Harry A. Drabkin, & Joëlle Roche. (2005). Sémaphorines et cancers : État des lieux. médecine/sciences. 21(6-7). 641–647. 4 indexed citations
10.
Kusy, Sophie, Vincent Potiron, Chan Zeng, et al.. (2005). Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1730(1). 66–76. 25 indexed citations
11.
Kusy, Sophie, Patrick Nasarre, Daniel C. Chan, et al.. (2005). Selective Suppression of In Vivo Tumorigenicity by Semaphorin SEMA3F in Lung Cancer Cells. Neoplasia. 7(5). 457–465. 59 indexed citations
12.
Roche, Joëlle, Chan Zeng, Anna E. Barón, et al.. (2004). Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics. Leukemia. 18(6). 1059–1063. 48 indexed citations
13.
Ferguson, Kevin L., François Guilhot, Laurence Lacotte, et al.. (2002). Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia. 16(2). 186–195. 150 indexed citations
14.
Roche, Joëlle & Harry A. Drabkin. (2001). The Role of Semaphorins in Lung Cancer. Clinical Lung Cancer. 3(2). 145–150. 11 indexed citations
15.
Brambilla, Élisabeth, Bruno Constantin, Harry A. Drabkin, & Joëlle Roche. (2000). Semaphorin SEMA3F Localization in Malignant Human Lung and Cell Lines. American Journal Of Pathology. 156(3). 939–950. 103 indexed citations
16.
Boldog, Ferenc, Robert M. Gemmill, James West, et al.. (1997). Chromosome 3p14 Homozygous Deletions and Sequence Analysis of FRA3B. Human Molecular Genetics. 6(2). 193–203. 117 indexed citations
17.
Berg, Anke van den, Miriam Hulsbeek, Debora de Jong, et al.. (1996). Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes and Cancer. 15(1). 64–72. 56 indexed citations
18.
Todd, S., et al.. (1995). YAC contigs covering an 8-megabase region of 3p deleted in the small-cell lung cancer cell line U2020. Genomics. 25(1). 19–28. 13 indexed citations
19.
Roche, Joëlle, et al.. (1993). DNase activity of micrococcal endonuclease covalently immobilized on nylon and polystyrene. Enzyme and Microbial Technology. 15(3). 215–221. 9 indexed citations
20.
Gourdon, Geneviève, et al.. (1992). Identification of GATA-1 and NF-E2 Binding Sites in the Flanking Regions of the Human Alpha-Globin Genes. Acta Haematologica. 87(3). 136–144. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Zwick Breakdown of academic impact, for papers by Gretchen Bain Breakdown of academic impact, for papers by Peter Ordentlich Breakdown of academic impact, for papers by Andreas Gschwind Breakdown of academic impact, for papers by John P. O’Bryan Breakdown of academic impact, for papers by Hua Miao Breakdown of academic impact, for papers by Tse‐Ming Hong Breakdown of academic impact, for papers by Matthew I. Wahl Breakdown of academic impact, for papers by Mireia Duñach Breakdown of academic impact, for papers by Jonathan A. Pachter
Rankless by CCL
2026